Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PRHSX vs GGHCX overlap: 59% of top holdings shared

Bottom line

How much do PRHSX and GGHCX overlap?

59% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 47.6% of PRHSX's assets and 48.2% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.

PRHSX holds far more positions (279 vs 82), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PRHSXGGHCX
Weight overlap (top 25)59%
Shared holdings12
Weight in shared holdings47.6%48.2%
Total positions27982
Expense ratio0.83%1.07%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings PRHSX and GGHCX have in common

Holding% of PRHSX% of GGHCXOverlap
Eli Lilly & Co14.28%10.59%10.59%
Johnson & Johnson6.63%6.76%6.63%
Unitedhealth Group Inc5.99%6.17%5.99%
Abbvie Inc5.10%4.03%4.03%
Merck & Co. Inc.4.01%4.59%4.01%
Gilead Sciences Inc2.82%3.63%2.82%
Thermo Fisher Scientific Inc2.52%1.55%1.55%
Vertex Pharmaceuticals Inc2.28%2.01%2.01%
Guardant Health Inc1.23%2.04%1.23%
Cardinal Health Inc1.03%2.10%1.03%
Cvs Health Corp0.94%2.52%0.94%
Brightspring Health Services0.82%2.20%0.82%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PRHSX

  1. Bristol-myers Squibb Co — 2.11%
  2. Abbott Laboratories — 1.89%
  3. Intuitive Surgical Inc — 1.87%
  4. Amgen Inc — 1.82%
  5. Stryker Corp — 1.78%
  6. Elevance Health Inc — 1.53%
  7. Natera Inc — 1.44%
  8. Danaher Corp — 1.43%
  9. Royalty Pharma Plc- Cl A — 0.97%
  10. Tenet Healthcare Corp — 0.94%
  11. Kymera Therapeutics Inc — 0.89%
  12. Protagonist Therapeutics Inc — 0.85%
  13. Moderna Therapeutics Inc — 0.83%

Only in GGHCX

  1. Invesco Private Prime Fund — 4.67%
  2. argenx SE — 3.24%
  3. Welltower Inc. — 2.34%
  4. Royalty Pharma PLC — 2.13%
  5. Invesco Private Government Fund — 1.80%
  6. Axsome Therapeutics, Inc. — 1.58%
  7. Edwards Lifesciences Corp. — 1.56%
  8. Invesco Treasury Portfolio — 1.56%
  9. BridgeBio Pharma, Inc. — 1.43%
  10. Waters Corp. — 1.41%
  11. IQVIA Holdings Inc. — 1.32%
  12. U C B S.a. — 1.24%
  13. Ligand Pharmaceuticals Inc. — 1.18%

Asset mix

Asset typePRHSXGGHCX
Stocks96.4%97.5%
Cash & short-term funds0.7%8.8%
Preferred stock3.0%—
Bonds0.2%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryPRHSXGGHCX
US92.6%93.5%
NL1.0%3.4%
GB1.7%3.1%
CH0.5%2.7%
BE—1.2%
DK0.7%1.1%
IE0.8%0.6%
BM0.7%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do PRHSX and GGHCX overlap?
About 59% by weight. 12 securities appear in both funds' top 25 holdings; they make up 47.6% of PRHSX's assets and 48.2% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PRHSX and GGHCX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, Unitedhealth Group Inc, Abbvie Inc, Merck & Co. Inc..
Should I own both PRHSX and GGHCX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PRHSX or GGHCX?
PRHSX is broader, with 279 positions versus 82 for GGHCX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.